232SM303 ASCEND clinical trial 'A Phase 3b Study to evaluate higher dose Nusinersen in Patients with Spinal Muscular Atrophy

Activity: Consultancy › Professional

Description

advisory services and training evaluators regarding the Endurance Shuttle Box and Block Test (ESBBT) and motor fatigability Tests